Lv51
1208 积分 2025-06-05 加入
Current and emerging treatment options for transthyretin amyloid cardiomyopathy
1个月前
已完结
1F10, a λ Light Chain Amyloid-Specific Monoclonal Antibody for Targeted Therapy of AL Amyloidosis
1个月前
已关闭
1F10, a λ Light Chain Amyloid-Specific Monoclonal Antibody for Targeted Therapy of AL Amyloidosis
1个月前
已关闭
1F10, a λ Light Chain Amyloid-Specific Monoclonal Antibody for Targeted Therapy of AL Amyloidosis
1个月前
已关闭
MM-913: Defining Gene Expression Programs of Amyloidogenic Clonal Plasma Cells Characterized by Single-Cell B-Cell Receptor and Transcriptomic Profiling
1个月前
已完结
MM-913: Defining Gene Expression Programs of Amyloidogenic Clonal Plasma Cells Characterized by Single-Cell B-Cell Receptor and Transcriptomic Profiling
1个月前
已关闭
Multifaceted effects of N-glycosylation on amyloidogenic κ light chains in AL amyloidosis
1个月前
已完结
Advances in Chinese herbal medicine for diabetic wound treatment: from tradition to innovation
1个月前
已关闭
Real-world treatment patterns, costs, and outcomes in patients with AL amyloidosis: analysis of the Optum EHR and commercial claims databases
8个月前
已完结
Frontline Dara-CyBorD for AL amyloidosis: high response rates and cytogenetic insights from a real-world cohort
8个月前
已完结
皖公网安备34019202002308
